THE RELATIONSHIP BETWEEN AN OBJECTIVE RESPONSE TO CHEMOTHERAPY AND SURVIVAL IN ADVANCED COLORECTAL-CANCER

被引:74
作者
GRAF, W
PAHLMAN, L
BERGSTROM, R
GLIMELIUS, B
机构
[1] UPPSALA UNIV,DEPT STAT,UPPSALA,SWEDEN
[2] AKAD SJUKHUSET,DEPT ONCOL,UPPSALA,SWEDEN
关键词
D O I
10.1038/bjc.1994.345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This analysis was conducted to evaluate the independent relationship between survival and response to chemotherapy in advanced colorectal cancer. In order to correct for the guarantee time effect, patients dying before the response evaluation were excluded from the analyses. A previously constructed prognostic model containing 11 variables was applied to 324 patients. When the response categories were analysed together with the prognostic variables, it was found that a response was associated with a definite survival advantage (P<O.001), whereas the influence of all the other variables decreased. The corrected survival advantage (relative progressive disease) was 11 months after a complete response, 6 months after a partial response and 4 months after stable disease. The survival advantage was of a similar magnitude when the analyses were repeated in an independent population comprising 198 patients in whom the prognostic model was extended to include also a set of laboratory values. The results show that a response to chemotherapy is associated with a longer survival also after correction for the guarantee time effect and the distribution of prognostic variables.
引用
收藏
页码:559 / 563
页数:5
相关论文
共 25 条
[1]   DOES CHEMOTHERAPY IMPROVE SURVIVAL IN ADVANCED BREAST-CANCER - A STATISTICAL OVERVIEW [J].
AHERN, RP ;
EBBS, SR ;
BAUM, MB .
BRITISH JOURNAL OF CANCER, 1988, 57 (06) :615-618
[2]   ANALYSIS OF SURVIVAL BY TUMOR RESPONSE [J].
ANDERSON, JR ;
CAIN, KC ;
GELBER, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) :710-719
[3]   SEQUENTIAL 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH ADVANCED SYMPTOMATIC GASTROINTESTINAL CANCER [J].
CARLSSON, G ;
GRAF, W ;
GUSTAVSSON, BG ;
GLIMELIUS, B ;
PAHLMAN, L ;
SPEARS, PC .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (08) :874-876
[4]  
COX DR, 1972, J R STAT SOC, V34, P1867
[5]   SEQUENTIAL METHOTREXATE-5-FU-LEUCOVORIN (MFL) IN ADVANCED COLORECTAL-CANCER [J].
GLIMELIUS, B ;
GINMAN, C ;
GRAFFMAN, S ;
PAHLMAN, L ;
STAHLE, E .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (03) :295-300
[6]   QUALITY OF LIFE DURING CYTOSTATIC THERAPY FOR ADVANCED SYMPTOMATIC COLORECTAL-CARCINOMA - A RANDOMIZED COMPARISON OF 2 REGIMENS [J].
GLIMELIUS, B ;
HOFFMAN, K ;
OLAFSDOTTIR, M ;
PAHLMAN, L ;
SJODEN, PO ;
WENNBERG, A .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (05) :829-835
[7]  
GLIMELIUS B, 1994, CANCER, V75, P556
[8]   DETERMINANTS OF PROGNOSIS IN ADVANCED COLORECTAL-CANCER [J].
GRAF, W ;
GLIMELIUS, B ;
PAHLMAN, L ;
BERGSTROM, R .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (09) :1119-1123
[9]  
GRAF W, 1994, IN PRESS EUR J CANCE
[10]   ASSESSMENT OF RESPONSE TO THERAPY IN ADVANCED BREAST-CANCER - PROJECT OF PROGRAM ON CLINICAL ONCOLOGY OF "INTERNATIONAL-UNION-AGAINST-CANCER, GENEVA, SWITZERLAND [J].
HAYWARD, JL ;
RUBENS, RD ;
CARBONE, PP ;
HEUSON, JC ;
KUMAOKA, S ;
SEGALOFF, A .
BRITISH JOURNAL OF CANCER, 1977, 35 (03) :292-298